4 unknown. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 4 |
| Phase 2 | 1 | Unknown 1 |
Follow Gallbladder Diseases: new trials by email Literature Review of Gallbladder Diseases trials Research Report on Gallbladder Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Food Effect on the Bioavailability of 4-MUST, Tablets, 128 mg 4-MUST, 2 tablets, fasted, 4-MUST, 2 tablets, after meals - Cholecystitis | Phase 1 | Unknown | Valenta Pharm JSC | 24 | 2024-03-19 | 2024-04-02 |
| Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral Administration in Healthy Volunteers 4-MUST, 1 tablet, 4-MUST, 2 tablets, 4-MUST, 3 tablets - Cholecystitis | Phase 1 | Unknown | Valenta Pharm JSC | 42 | 2023-12-04 | 2024-03-18 |
| A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies Cannabidiol, Bortezomib, Leucovorin - Cancer of Pancreas, Cancer of Liver | Phase 1 / Phase 2 | Unknown | Leaf Vertical Inc. | 160 | 2019-01-15 | 2018-07-31 |
| T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System Recombinant Human Interleukin-2, HER2Bi-Armed T Cells - Esophageal Cancer, Gastric Cancer | Phase 1 | Unknown | Yi Miao | 6 | 2016-02-01 | 2016-01-25 |
Cholecystitis (2) · Gallbladder Neoplasms (2) · Liver Neoplasms (2) · Pancreatic Neoplasms (2) · Colonic Neoplasms (1) · Esophageal Neoplasms (1) · Glioblastoma (1) · Intestinal Neoplasms (1) · Multiple Myeloma (1) · Rectal Neoplasms (1) · Stomach Neoplasms (1)
Biliary Tract Diseases (4) · Digestive System Diseases (4) · Biliary Tract Neoplasms (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Intestinal Diseases (2) · Liver Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Pancreatic Diseases (2) · Astrocytoma (1)
Bevacizumab (1) · Bortezomib (1) · Cannabidiol (1) · Fluorouracil (1) · Gemcitabine (1) · Irinotecan (1) · Leucovorin (1) · Oxaliplatin (1) · Postprandial Period (1) · Temozolomide (1) · aldesleukin (1)
Valenta Pharm JSC (2) · Leaf Vertical Inc. (1) · Yi Miao (1)
Russia (2) · China (1) · United States (1)
Sarah F Katta, DO (1) · Yi Miao, PH.D (1)